Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.

Maria-Luisa Schubert | Anita Schmitt | Angela Hückelhoven-Krauss | Brigitte Neuber | Alexander Kunz | Philip Waldhoff | Dominik Vonficht | Schayan Yousefian | Lea Jopp-Saile | Lei Wang | Felix Korell | Anna Keib | Birgit Michels | Dominik Haas | Tim Sauer | Patrick Derigs | Andreas Kulozik | Joachim Kunz | Petra Pavel | Sascha Laier | Patrick Wuchter | Johann Schmier | Gesine Bug | Fabian Lang | Nicola Gökbuget | Jochen Casper | Martin Görner | Jürgen Finke | Andreas Neubauer | Mark Ringhoffer | Denise Wolleschak | Monika Brüggemann | Simon Haas | Anthony D Ho | Carsten Müller-Tidow | Peter Dreger | Michael Schmitt
Journal of hematology & oncology | 2023

Third-generation chimeric antigen receptor (CAR)-engineered T cells (CARTs) might improve clinical outcome of patients with B cell malignancies. This is the first report on a third-generation CART dose-escalating, phase-1/2 investigator-initiated trial treating adult patients with refractory and/or relapsed (r/r) acute lymphoblastic leukemia (ALL).

Pubmed ID: 37481608

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


ClinicalTrials.gov (tool)

RRID:SCR_002309

Registry and results database of federally and privately supported clinical trials conducted in United States and around world. Provides information about purpose of trial, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.Offers information for locating federally and privately supported clinical trials for wide range of diseases and conditions. Research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings. ClinicalTrials.gov contains trials sponsored by National Institutes of Health, other federal agencies, and private industry. Studies listed in database are conducted in all 50 States and in 178 countries.

View all literature mentions

Miltenyi Biotec (tool)

RRID:SCR_008984

An Organization portal, Antibody supplier, Service resource,

View all literature mentions

BD Biosciences (tool)

RRID:SCR_013311

An Antibody supplier

View all literature mentions

CATALYST (tool)

RRID:SCR_017127

Software R package to provide pipeline for preprocessing of cytometry data, including normalization using bead standards, single cell deconvolution, and bead based compensation.

View all literature mentions